Literature DB >> 9078209

Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression.

D F Mirza, B K Gunson, Z Soonawalla, J Pirenne, A D Mayer, J A Buckels, P McMaster.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9078209     DOI： 10.1016/s0140-6736(05)60138-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies.

Authors:  G Morris-Stiff; A Khan; I Quiroga; R Baboo; W A Jurewicz
Journal:  BMJ       Date:  1999-10-23

2.  Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation.

Authors:  Timothy M Schmitt; Melissa Phillips; Robert G Sawyer; Patrick Northup; Klaus D Hagspiel; Timothy L Pruett; Hugo J R Bonatti
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

Review 3.  Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

Authors:  C M Spencer; K L Goa; J C Gillis
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.